Evidence map›Paper›PMID 38861162›Full record

Observational studyEuropean radiology2024

Cerebral collaterals are associated with pre-treatment brain-blood barrier permeability in acute ischemic stroke patients.

Alexandre Bani-Sadr, Laura Mechtouff, Marc Hermier, Omer F Eker, Lucie Rascle, Charles de Bourguignon, Timothe Boutelier, Anna Martin, Emanuele Tommasino, Elodie Ong and 5 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in European radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alexandre Bani-SadrDepartment of Neuroradiology, East Group Hospital, Hospices Civils de Lyon, Bron, France. apbanisadr@gmail.com.ORCID http://orcid.org/0000-0002-1808-2484
Laura MechtouffStroke Department, East Group Hospital, Hospices Civils de Lyon, Bron, France.
Marc HermierDepartment of Neuroradiology, East Group Hospital, Hospices Civils de Lyon, Bron, France.
Omer F EkerDepartment of Neuroradiology, East Group Hospital, Hospices Civils de Lyon, Bron, France.
Lucie RascleStroke Department, East Group Hospital, Hospices Civils de Lyon, Bron, France.
Charles de BourguignonClinical Investigation Center, INSERM 1407, Bron, France.
Timothe BoutelierOlea Medical, La Ciotat, France.
Anna MartinDepartment of Neuroradiology, East Group Hospital, Hospices Civils de Lyon, Bron, France.
Emanuele TommasinoDepartment of Neuroradiology, East Group Hospital, Hospices Civils de Lyon, Bron, France.
Elodie OngStroke Department, East Group Hospital, Hospices Civils de Lyon, Bron, France.
Julia FontaineStroke Department, East Group Hospital, Hospices Civils de Lyon, Bron, France.
Tae-Hee ChoStroke Department, East Group Hospital, Hospices Civils de Lyon, Bron, France.
Laurent DerexStroke Department, East Group Hospital, Hospices Civils de Lyon, Bron, France.
Norbert NighoghossianStroke Department, East Group Hospital, Hospices Civils de Lyon, Bron, France.
Yves BerthezeneDepartment of Neuroradiology, East Group Hospital, Hospices Civils de Lyon, Bron, France.

Funding

Agence Nationale de la Recherche ANR-16-RHUS-0009
6 · The paper itself

Abstract

introductionTo investigate the relationship between collaterals and blood-brain barrier (BBB) permeability on pre-treatment MRI in a cohort of acute ischemic stroke (AIS) patients treated with thrombectomy.

methodsWe conducted a retrospective analysis of the HIBISCUS-STROKE cohort, a single-center observational study that enrolled patients treated with thrombectomy from 2016 to 2022. Dynamic-susceptibility MRIs were post-processed to generate K2 maps with arrival-time correction, which were co-registered with apparent diffusion coefficient (ADC) maps. The 90th percentile of K2 was extracted from the infarct core-defined by an ADC ≤ 620 × 10

resultsOut of 249 enrolled, 101 (40.6%) were included (median age: 72.0 years, 52.5% of males, median NIHSS score at admission: 15.0). Patients with poor collaterals (n = 44) had worse NIHSS scores (median: 16.0 vs 13.0, p = 0.04), larger infarct core volumes (median: 43.7 mL vs 9.5 mL, p < 0.0001), and higher increases in K2 (median: 346.3% vs 152.7%, p = 0.003). They were less likely to achieve successful recanalization (21/44 vs 51/57, p < 0.0001) and experienced more frequent hemorrhagic transformation (16/44 vs 9/57, p = 0.03). On multiple variable analysis, poor collaterals were associated with larger infarct cores (odds ratio (OR) = 1.12, 95% confidence interval (CI): [1.07, 1.17], p < 0.0001) and higher increases in K2 (OR = 6.63, 95% CI: [2.19, 20.08], p = 0.001).

conclusionPoor collaterals are associated with larger infarct cores and increased BBB permeability at admission MRI. CLINICAL RELEVANCE STATEMENT: Poor collaterals are associated with a larger infarct core and increased BBB permeability at admission MRI of AIS patients treated with thrombectomy. These findings may have translational interests for extending thrombolytic treatment eligibility and developing neuroprotective strategies. KEY POINTS: In AIS, collaterals and BBB disruption have been both linked to hemorrhagic transformation. Poor collaterals were associated with larger ischemic cores and increased BBB permeability on pre-treatment MRI. These findings could contribute to hemorrhagic transformation risk stratification, thereby refining clinical decision-making for reperfusion therapies.

Indexed as

Blood-Brain BarrierCollateral CirculationIschemic StrokeThrombectomyAgedAged, 80 and overAngiography, Digital SubtractionFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedRetrospective StudiesMR perfusionStrokeThrombectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.